Africa: Third wave hits continent as Covid vaccine imports dry up
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
N’DJAMENA, Chad (AP) — At the small hospital where Dr. Oumaima Djarma works in Chad’s capital, there are no debates over which coronavirus vaccine is the best.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
WASHINGTON (AP) — The National Institutes of Health is launching research to understand the causes and consequences of the lingering brain fog, breathing problems and malaise reported by many recovering COVID-19 patients.
Dr. Anthony Fauci says some studies have shown up to 30% of patients report symptoms that can endure for months, complicating their return to normal routines and work, and plunging many recovering patients into depression.
Fauci noted at a White House coronavirus briefing on Wednesday that work at NIH started this week thanks to more than $1 billion provided by Congress for COVID-related medical research. Government scientists are looking to enlist doctors and research institutions around the country in the effort to learn about “long-haul” COVID-19.
Submitted by mike kraft on
Submitted by mike kraft on
France is on track to reach its target of vaccinating 1 million people by the end of January and has enough doses to increase the total to 2.4 million by the end of February.